InSphero is attending EASD 2026
Join us at the 62nd EASD Annual Meeting 2026 in Milan, where the global diabetes community comes together to share the latest advances in diabetes research, treatment, and care.
We’re looking forward to engaging with the field around how human-relevant 3D in vitro models can support a deeper understanding of diabetes and metabolic disease. By combining physiologically relevant biology with robust, scalable workflows, our platforms are designed to help generate consistent, decision-ready data across diabetes research and drug development.
Don’t miss the opportunity to connect with our team, exchange perspectives, and explore how these approaches can be applied within your own research workflows.
Explore all our activities taking place during EASD 2026, from Monday, September 28th to Friday, October 2nd. See you in Milan!
Quick navigation
Scientific Presentation at EASD 2026
Standardised and scalable 3D human islet platforms for benchmarking and screening of immunomodulatory therapeutics in type 1 diabetes
Date: Wednesday, September 30 2026 | 10:15 – 10:30
Location: Paris Hall
Session: OP 15 Protecting beta cells: stopping autoimmunity in its tracks